Literature DB >> 25681847

Hormonal and nonhormonal treatment of vasomotor symptoms.

Miriam S Krause1, Steven T Nakajima2.   

Abstract

This article focuses on the cause, pathophysiology, differential diagnosis of, and treatment options for vasomotor symptoms. In addition, it summarizes important points for health care providers caring for perimenopausal and postmenopausal women with regard to health maintenance, osteoporosis, cardiovascular disease, and vaginal atrophy. Treatment options for hot flashes with variable effectiveness include systemic hormone therapy (estrogen/progestogen), nonhormonal pharmacologic therapies (selective serotonin reuptake inhibitors, selective norepinephrine reuptake inhibitors, clonidine, gabapentin), and nonpharmacologic therapy options (behavioral changes, acupuncture). Risks and benefits as well as contraindications for hormone therapy are further discussed.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Estrogen; Menopause; Progestogen; SNRI; SSRI; Vasomotor symptoms

Mesh:

Substances:

Year:  2014        PMID: 25681847     DOI: 10.1016/j.ogc.2014.09.008

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  13 in total

1.  Estrogen deprivation does not affect vascular heat shock response in female rats: a comparison with oxidative stress markers.

Authors:  Antônio Azambuja Miragem; Mirna Stela Ludwig; Thiago Gomes Heck; Fernanda Giesel Baldissera; Analu Bender dos Santos; Matias Nunes Frizzo; Paulo Ivo Homem de Bittencourt
Journal:  Mol Cell Biochem       Date:  2015-06-05       Impact factor: 3.396

Review 2.  Flushing in (neuro)endocrinology.

Authors:  Fady Hannah-Shmouni; Constantine A Stratakis; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 3.  Current Treatment Options: Headache Related to Menopause-Diagnosis and Management.

Authors:  Clinton G Lauritsen; Abigail L Chua; Stephanie J Nahas
Journal:  Curr Treat Options Neurol       Date:  2018-03-06       Impact factor: 3.598

Review 4.  Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.

Authors:  Chris Stubbs; Lisa Mattingly; Steven A Crawford; Elizabeth A Wickersham; Jessica L Brockhaus; Laine H McCarthy
Journal:  J Okla State Med Assoc       Date:  2017-05

5.  Buspirone Nanovesicular Nasal System for Non-Hormonal Hot Flushes Treatment.

Authors:  Elka Touitou; Hiba Natsheh; Shaher Duchi
Journal:  Pharmaceutics       Date:  2018-07-03       Impact factor: 6.321

6.  Comparison of the effects of stellate ganglion block and paroxetine on hot flashes and sleep disturbance in breast cancer survivors.

Authors:  Poupak Rahimzadeh; Farnad Imani; Nahid Nafissi; Behzad Ebrahimi; Seyed Hamid Reza Faiz
Journal:  Cancer Manag Res       Date:  2018-10-26       Impact factor: 3.989

7.  Health-Promoting Behaviors and Menopausal Symptoms: An Interventional Study in Rural India.

Authors:  Ekta Malik; Poonam Sheoran; Adiba Siddiqui
Journal:  J Midlife Health       Date:  2018 Oct-Dec

8.  Acupoint injection treatment for primary osteoporosis: A systematic review and meta-analysis of randomized controlled trials protocol.

Authors:  Rui Huang; Shihong Xu; Dingpeng Li; Xingwen Xie
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

9.  Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials.

Authors:  Gaetano Riemma; Antonio Schiattarella; Marco La Verde; Giuseppina Zarobbi; Simone Garzon; Gaspare Cucinella; Gloria Calagna; Domenico Labriola; Pasquale De Franciscis
Journal:  Medicina (Kaunas)       Date:  2019-08-31       Impact factor: 2.430

Review 10.  Beer Polyphenols and Menopause: Effects and Mechanisms-A Review of Current Knowledge.

Authors:  Berner Andrée Sandoval-Ramírez; Rosa M Lamuela-Raventós; Ramon Estruch; Gemma Sasot; Monica Doménech; Anna Tresserra-Rimbau
Journal:  Oxid Med Cell Longev       Date:  2017-08-17       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.